Regulatory inspections of interactive response technology systems have surged 140% since 2022, signaling intensified global scrutiny of data integrity, randomization, and system validation in clinical trials.
Justine Koor
Advertisement
Justine Koor, Director, Quality Assurance at IQVIA
Articles by Justine Koor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Integrating AI Across Legacy Clinical Trial Systems
2
Reimagining Clinical Operations Through Artificial Intelligence
3
Balancing Human Oversight and Automation in AI-Driven Trials
4
Preparation Tips to Minimize Impact of Regulatory Inspections for IRT Systems
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
